Pharmacological modulation of secondary mediator systems - cyclic AMP and cyclic GMP - on inflammatory hyperalgesia

British Journal of Pharmacology

Volumn 127, Issue 3, 1999, Pages 671-678

  Cunha, F Q ^a   Teixeira, M M ^b   Ferreira, S H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cyclic AMP; Cyclic GMP; Cytokines; Dopamine; Inflammatory hyperalgesia; ODQ; PDEs; Prostaglandin E2; Protein kinase A; Rolipram; SNAP

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BRADYKININ; CARRAGEENAN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; DOPAMINE; GUANYLATE CYCLASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; PICLAMILAST; PROSTAGLANDIN E2; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; HYPERALGESIA; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRADYKININ; CARRAGEENAN; CYCLIC AMP; CYCLIC GMP; DINOPROSTONE; DOPAMINE; HYPERALGESIA; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; ISOQUINOLINES; MALE; OXADIAZOLES; PHOSPHODIESTERASE INHIBITORS; PYRROLIDINONES; QUINOXALINES; RATS; RATS, WISTAR; ROLIPRAM; SECOND MESSENGER SYSTEMS; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033040929     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702601     Document Type: Article

References (56)

1. Aantaa, R., Marjamaki, A. & Scheinin, M. (1995). Molecular pharmacology of (-2 adrenoceptor subtypes. Ann. Med., 27, 439-449.
2. Coderre, T.J. (1992). Contribution of protein kinase C to central sensitization and persistent pain following tissue injury. Neurosci. Lett., 140, 181-184.
3. Coderre, T.J., Abbott, F.V., & Melzack, R. (1984). Effects of peripheral antisympathetic treatments in the tail-flick, formalin and autotomy tests. Pain, 18, 13-23.
4. Coderre, T.J. & Yashpal, K. (1994). Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur. J. Neurosci., 6, 1328-1334.
5. Coleman, R.A., Smith, W.I., & Narumiya, S. (1994). VHI, International union of pharmacology classification of prostanoids receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205-229.
6. Cunha, F.Q., Lorenzetti, B.B., Poole, S. & Ferreira, S.H. (1991). Interleukin-8 as a mediator of sympathetic pain, Br. J. Pharmacol., 104, 765-767.
7. Cunha, F.Q., Poole, S., Lorenzetti, B.B. & Ferreira, S.H. (1992). The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol., 107, 660-664.
8. Duarte, I.D.G., Lorenzetti, B.B. & Ferreira, S.H. (1990). Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol., 186, 289-293.
9. Duarte, I.D.G., Nakamura, M. & Ferreira, S.H. (1988). Participation of the sympathetic system in acetic acid-induced writhing in mice. Brazilian J. Med. Biol. Res., 21, 341-343.
10. Eigler, A., Siegmund, B., Emmerich, U., Baumann, K., Hartmann, G. & Endres, S. (1998). Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J. Leukocyte Biology, 63, 101-107.
11. Ferreira, S.H. (1990). A classification of peripheral analgesics based upon their mode of action. In: Migraine: Spectrum of ideas. eds. Sandler, M. & Collins, G.M. 59-72. Oxford University Press.
12. Ferreira, S.H., Duarte, I.D.G. & Lorenzetti, B.B. (1991). The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release, Eur. J. Pharmacol, 201, 121-122.
13. Ferreira, S.H., Lorenzetti, B.B., Bristow, A.F. & Poole, S. (1988). Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 334, 698-700.
14. Ferreira, S.H., Lorenzetti, B.B. & Correa, F.M.A. (1978). Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol., 53, 39-48.
15. Ferreira, S.H., Lorenzetti, B.B. & Faccioli, L.H. (1992). Blockade of hyperalgesia and neurogenic oedema by topical application of nitroglycerin. Eur. J. Pharmacol., 217, 207-209.
16. ++ dependent process. Prostaglandins. 18, 179-190.
17. 2. Prostaglandins, 16, 31-37.
18. Garry, M.G., Richardson, J.D. & Hargreaves, K.M. (1994). Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res., 646, 135-139.
19. Granados-Soto, V., Rufino, M. Deo., Gomes, Lopes, L.D. & Ferreira, S.H. (1997). Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol., 340, 177-180.
20. Haley, J.E., Dickenson, A.H., Schachter, M. (1992). Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacol., 31, 251-258.
21. Handwerker, H.O. (1976). Influences of algogenic substances on the discharges of unmyelinated cutaneous nerve fibres identified as nociceptor. In: Advances in pain research and therapy. eds. Bonica, J.J. & Albe-Fessard, D. Vol. 1, pp. 41-45. New York: Raven Press.
22. Hingtgen, C.M., Waite, K.J. & Vasko, M.R. (1995). Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J. Neurosci., 15, 5411-5419.
23. Inoue, T., Mashimo, T., Shibata, M., Shibuta, S. & Yoshiya, I. (1998). Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model. Brain Res., 792, 263-270.
24. Kawabata, A., Manabe, S., Manabe, Y. & Takagi, H. (1994). Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol., 112, 547-550.
25. Kress, M., Rodl, J. & Reeh, P.W. (1996). Stable analogues of cyclic AMP but not cyclic GMP sensitize unmyelinated primary afferents in rat skin to heat stimulation but not to inflammatory mediators, in vitro. Neuroscience, 74, 609-617.
26. Lorenzetti, B.B. & Ferreira, S.H. (1996). Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm. Res., 45, 308-311.
27. Lin, Q., Peng, Y.B. & Willis, W.D. (1996). Possible role of protein kinase C in the sensitization of primate spinothalamic tract neurons. J. Neurosci., 16, 3026-3034.
28. Lynn, B. & O'Shea, N.R. (1998). Inhibition of forskolin-induced sensitisation of frog skin nociceptors by the cyclic AMP-dependent protein kinase A antagonist H-89. Brain Res., 780, 360-362.
29. Malmberg, A.B. & Yaksh, T.L. (1993). Spinal nitric oxide synthase inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Paim, 54, 291-300.
30. Mcmahon, S.B. & Koltzenburg, M. (1990). Novel classes of nociceptors: beyond Sherrington. TINS, 13, 199-201.
31. Meller, S.T., Cummings, C.P., Traub, R.J. & Gebhart, G.F. (1994). The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience, 60, 367-374.
32. Meller, S.T., Pechman, P.S., Gebhart, G.F. & Maves, T.J. (1992). Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience, 50, 7-10.
33. Messlinger, K. (1997). What is a nociceptor? Anaesthesist, 46, 142-153.
34. Moncada, S., Ferreira, S.H. & Vane, J.R. (1975). Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur. J. Pharmacol., 31, 250-260.
35. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol., 102, 198-202.
36. G-nitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse. Br. J. Pharmacol., 106, 493-497.
37. Moro, M.A., Russell, R.J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W. & Moncada, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
38. G-nitro arginine methyl ester-induced antinociception in mice: a role for serotonergic and adrenergic neurons. Gen. Pharmacol., 23, 1177-1182.
39. Nakamura, M. & Ferreira, S.H. (1987). A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol., 135, 145-153.
40. Namba, T., Oida, H., Sugimoto, Y., Kakizuka, A., Negishi, M., Ichikawa, A. & Narumiya, S. (1994). cDNA cloning of a mouse prostacyclin receptor. J. Biol. Chem., 269, 9986-9992.
41. 2-induced mechanical hyperalgesia in the rat. Neuroscience, 64, 769-776.
42. Perl, E.R. (1976). Sensitization of nociceptors and its relation to sensation. In: Advances in pain research and therapy, eds. Bonica, J.J. and Albe-Fessard, D. Vol. 1, pp. 17-34. New York: Raven Press.
43. Poole, S., Cunha, F.Q., Selkirk, S., Lorenzetti, B.B. & Ferreira, S.H. (1995). Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pharmacol., 115, 684-688.
44. Sluka, K.A. (1997). Activation of the cAMP transduction cascade contributes to the mechanical hyperalgesia and allodynia induced by intradermal injection of capsaicin. Br. J. Pharmacol., 122, 1165-1173.
45. Sluka, K.A., Rees, H., Chen, P.S., Tsurouka, M. & Willis, W.D. (1997). Capsaicin-induced sensitization of primate spinothalamic tract cells is prevented by a protein kinase C inhibitor. Brain Res., 772, 82-86.
46. Smith, J.A.M., Amagasu, S.M., Eglen, R.M., Hunter, J.C. & Bley, K.R. (1998). Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br. J. Pharmacol., 124, 513-523.
47. Taiwo, Y.O., Bjerknes, L.K., Goetzl, E.J. & Levine, J.D. (1989). Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience, 32, 577-580.
48. Taiwo, Y.O., Heller, P.H. & Levine, J.D. (1992). Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience, 48, 479-483.
49. Taiwo, Y.O. & Levine, J.D. (1991). Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience, 44, 131-135.
50. Taniguchi, K., Shinjo, K., Mizutani, M., Shimada, K., Ishikawa, T., Menniti, F.S. & Nagahisa, A. (1997). Anti-nociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist. Br. J. Pharmacol., 122, 809-812.
51. Teixeira, M.M., Gristwood, R.W., Cooper, N. & Hellewell, P.G. (1997). Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol. Sci., 18, 164-167.
52. Tonussi C.R. & Ferreira, S.H. (1994). Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization, Eur. J. Pharmacol., 251, 173-179.
53. Wall, P.D. & Gutnick, M. (1974). Ongoing activity in peripheral nerves: The physiology and pharmacology of impulses originating from a neuroma. Exp. Neurol., 43, 580.
54. 2 in the rat is inhibited by guanosine 5′-O-(2-thiodiphosphate), 2′,5′-didcoxyadenosine and Walsh inhibitor peptide. Neuroscience, 71, 259-263.
55. Watkins, L.R., Goehler, L.E., Relton, J., Brewer, M.T. & Maier, S.F. (1995). Mechanisms of tumour necrosis factor α(TNFα) hyperalgesia, Brain Res., 692, 244-250.
56. Watkins, L.R., Wiertelak, E.P., Goehler, L.E., Smith, K.P., Martin, D. & Maier, S.F. (1994). Characterization of cytokine-induced hyperalgesia. Brain Res., 654, 15-26.